1 Product identity
Ingredient risk
No flagged ingredients

Cellgevity

BrandMax InternationalOther Combinations Capsule 19 ingredients DSLD #26541
Net contents: 120 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-10-25
2 Ingredients (19)
IngredientGroupSafety
Vitamin CVitamin CGenerally Safe
SeleniumSeleniumConditionally Safe
RiboCeine(R)Ribose-l-cysteine
Proprietary BlendProprietary Blend (Combination)
CordycepsCordycepsConditionally Safe
CurcuminCurcumin
ResveratrolResveratrolConditionally Safe
Alpha Lipoic AcidAlpha Lipoic Acid
QuercetinQuercetinConditionally Safe
Milk Thistle ExtractMilk ThistleGenerally Safe
Broccoli extractBroccoli
Aloe ExtractAloe
BioPerineBlack Pepper
Gelatin Capsulescapsule
Soy Lecithinlecithin
Microcrystalline CelluloseCellulose
Stearic AcidStearic Acid
Silicon DioxideSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Selenium — Conditionally Safe
⚠ Selenosis >400 mcg
⚠ Diabetes risk at high doses
Cordyceps — Conditionally Safe
⚠ May slow blood clotting
⚠ May lower blood glucose
Resveratrol — Conditionally Safe
⚠ Estrogenic activity
⚠ CYP enzyme inhibition
Grape Seed Extract — Limited Evidence
⚠ Antiplatelet effect
⚠ May interact with anticoagulants
Quercetin — Conditionally Safe
⚠ Inhibits CYP3A4
⚠ Affects cyclosporine levels
Milk Thistle — Generally Safe
⚠ Mild GI
⚠ Asteraceae allergy
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID26541
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-10-25
6 More from Max International
View Max International Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Cellgevity — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Sep 01]. Available from: https://supplement.ge/products/cellgevity-26541/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network